| Article

Newswise — An experimental, off-the-shelf immunotherapy that combines a targeted antibody and chemotherapy can lead to potentially durable responses in multiple myeloma patients whose disease has relapsed or is resistant to other standard therapies. A multi-center, international trial evaluated the...

| Article

Newswise — Opioids play an important role in how cancer patients manage pain, but the ongoing opioid epidemic has raised concerns about their potential for abuse.

Pain remains one of the most difficult symptoms associated with cancer. More than half of cancer patients undergoing treatment...

| Article

Newswise — A Mayo Clinic-led study involving 488 cardiac patients whose cases were followed for up to 12 years finds that microvascular endothelial dysfunction, a common early sign of cardiovascular disease, is associated with a greater than twofold risk of cancer.

The study, published in the Eur...

| Article

Between 2005 and 2015, as the opioid crisis in America came into focus, prescriptions for gabapentinoid medications -- gabapentin and pregabalin -- to adults with cancer saw a two-fold increase, a University of Michigan Rogel Cancer Center study has found.

Gabapentin, which affects voltage-gated...

| Article

Newswise — A new multisite study funded by the National Institute on Aging will examine whether co-occurring Alzheimer’s disease and stage 4 breast or prostate cancer alters pain perception, potentially leading to undertreated cancer pain.

The five-year project, led by primary investigators...

| Article

Newswise — It's well known that exercise is good for preventing and treating many forms of heart disease, but less commonly known are the benefits of physical activity for people living with and beyond cancer.

A new initiative called Moving Through Cancer -- led by Kathryn Schmitz, professor of...

| Article

Newswise — A new blood test in development has shown ability to screen for numerous types of cancer with a high degree of accuracy, a trial of the test shows. Dana-Farber Cancer Institute investigators will present the results of the multi-center trial during a session today at the European Society...

| Article

Newswise — Loyola Medicine is among the first centers to offer a new minimally invasive prostate biopsy that minimizes the risk of infection and may increase the cancer detection rate.

It's called the transperineal prostate biopsy.

A urologist may recommend a biopsy if a digital rectal exam or...

| Article

Newswise — In experiments in mice, Johns Hopkins researchers say they have developed a technique that facilitates the precise placement of cancer drugs at their intended targets in the brain. This approach pairs a technique that guides a catheter through the brain’s arteries with positron emission...

| Article

Newswise — A worldwide coalition of researchers and clinicians has agreed that light therapy is among the most effective interventions for the prevention of oral mucositis, painful ulcers in the mouth resulting from cancer therapy.

The new guidelines from the Multinational Association of...

Subscribe to cancer

Sign-Up